In addition, we found that IL-6 levels were also significantly higher in SOD1 TG mice compared to WT mice (Fig 1C), suggesting that IL-6 may be a therapeutic target of ALS. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.